Literature DB >> 1390337

Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells.

G L Prasad1, E M Valverius, E McDuffie, H L Cooper.   

Abstract

A full-length complementary DNA clone from a normal human mammary epithelial cell (strain 184) encoding a 25-kilodalton protein, HME1, was isolated. Expression of HME1 RNA appears to be limited to epithelial cells. The HME1 sequence has extensive sequence homology with bovine 14-3-3 protein, which is an activator of tyrosine and tryptophan hydroxylase. However, the tissue distribution, arrangement of charged amino acids, and location of potential phosphorylation sites of HME1 differ from those of 14-3-3. Compared with normal mammary epithelial cells, expression of HME1 RNA was dramatically low in two cell lines derived from human mammary carcinoma that were examined, and in a line of normal mammary epithelial cells transformed by oncogenes. HME1 therefore appears to be a cellular differentiation marker that may be down-regulated during neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390337

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  41 in total

1.  The G(2) checkpoint is maintained by redundant pathways.

Authors:  T M Passalaris; J A Benanti; L Gewin; T Kiyono; D A Galloway
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Inactivation of 14-3-3sigma influences telomere behavior and ionizing radiation-induced chromosomal instability.

Authors:  S Dhar; J A Squire; M P Hande; R J Wellinger; T K Pandita
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

3.  DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

Authors:  Sripathi M Sureban; Randal May; Stan A Lightfoot; Aimee B Hoskins; Megan Lerner; Daniel J Brackett; Russell G Postier; Rama Ramanujam; Altaf Mohammed; Chinthalapally V Rao; James H Wyche; Shrikant Anant; Courtney W Houchen
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

4.  Molecular evolution of the 14-3-3 protein family.

Authors:  W Wang; D C Shakes
Journal:  J Mol Evol       Date:  1996-10       Impact factor: 2.395

5.  14-3-3 sigma positively regulates p53 and suppresses tumor growth.

Authors:  Heng-Yin Yang; Yu-Ye Wen; Chih-Hsin Chen; Guillermina Lozano; Mong-Hong Lee
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

6.  Characterization of 14-3-3 proteins in adrenal chromaffin cells and demonstration of isoform-specific phospholipid binding.

Authors:  D Roth; A Morgan; H Martin; D Jones; G J Martens; A Aitken; R D Burgoyne
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

7.  14-3-3sigma, the double-edged sword of human cancers.

Authors:  Zhaomin Li; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Am J Transl Res       Date:  2009-06-08       Impact factor: 4.060

8.  Overexpression of 14-3-3σ counteracts tumorigenicity by positively regulating p73 in vivo.

Authors:  Cuizhi Geng; Meixiang Sang; Ruiling Yang; Wei Gao; Tao Zhou; Shijie Wang
Journal:  Oncol Lett       Date:  2011-08-31       Impact factor: 2.967

9.  Mechanism of inhibition of protein kinase C by 14-3-3 isoforms. 14-3-3 isoforms do not have phospholipase A2 activity.

Authors:  K Robinson; D Jones; Y Patel; H Martin; J Madrazo; S Martin; S Howell; M Elmore; M J Finnen; A Aitken
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

10.  Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers.

Authors:  Zhaomin Li; Zizheng Dong; David Myer; Michele Yip-Schneider; Jianguo Liu; Ping Cui; C Max Schmidt; Jian-Ting Zhang
Journal:  BMC Cancer       Date:  2010-11-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.